- VRDN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-Q/A Filing
Viridian Therapeutics (VRDN) 10-Q/A2014 Q3 Quarterly report (amended)
Filed: 23 Dec 14, 12:00am
Dated: December 23, 2014 | |
/s/ Tamara A. Seymour | |
Tamara A. Seymour | |
Chief Financial Officer (Principal Financial Officer) |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.